Biopharmaceutical Third-Party Logistics Market Size, Share & Trends Analysis Report by Supply Chain (Cold Chain, Non-cold Chain), By Service Type (Transportation, Warehousing & Storage), Region And Segment Forecasts, 2025-2034

Global Biopharmaceutical Third-Party Logistics Market Size is valued at USD 141.4 Bn in 2024 and is predicted to reach USD 264.8 Bn by the year 2034 at an 6.6% CAGR during the forecast period for 2025-2034.

Third-party logistics (3PL) for the biopharmaceutical industry describes the logistical support provided to pharmaceutical firms by unaffiliated businesses. For instance, it involves filling orders, keeping track of the inventory of the goods using a warehouse management system, and receiving medications consisting of tiny molecules into the warehouse. For instance, by reducing unnecessary overhead costs, ensuring continuous product supply, optimizing transportation, and increasing the organization's general efficiency, 3PL helps pharmaceutical and medical institutions maintain logistics for the distribution of medical medicines.

The pharmaceutical industry's tremendous rise is largely to blame for the market's optimistic outlook. The market is also increasing due to the rising trend among medical businesses to outsource logistics to increase their distribution network. Some of the major drivers propelling the market include the rising trend of outsourcing logistics, the concentration of pharmaceutical manufacturers on their distribution network due to its strong sales statistics, and an increase in the number of biosimilar launches. The COVID-19 pandemic had a substantial effect on market expansion.

Additionally, Celcius Logistics debuted its Hyper-Local temperature-controlled delivery services for food and pharmaceutical orders in November 2022. Over the past few years, the demand for outsourcing transportation services has seen a noticeable increase. Giant pharmaceutical corporations' overhead has decreased due to outsourcing the transportation services for transporting pharmaceutical medications. To further encourage lean management and using six sigma in their business operations, the major biopharma corporations are either consenting to or outsourcing to 3PL service providers.  

Competitive Landscape:

Some of the major key players in the Biopharmaceutical third-party logistics market are:

• DHL International GmbH
• SF Express
• United Parcel Service of America Inc.
• AmerisourceBergen Corp.
• DB Schenker
• Kuehne and Nagel
• Kerry Logistics Network Ltd.
• Agility 

Market Segmentation:

The Biopharmaceutical third-party logistics market is segmented on the basis of supply chain and service type.Supply chain segments includes Cold Chain and Non-Cold Chain. The market is segmented by service type into Transportation, Warehousing & Storage, and Others.

Based On Service Type, The Warehousing And Storage Segment Is Accounted As A Major Contributor In The Biopharmaceutical Third-Party Logistics Market

In 2022, the warehousing and storage industry dominated the market, generating more than 43.30% of the total revenue. The increasing demand for 3PL services from the pharmaceutical and healthcare sectors is to blame for this. The life sciences industry is using 3PL services to lower overhead expenditures and operating costs.

The Cold Chain Segment Witnessed Growth At A Rapid Rate

Over the forecast period, the cold chain segment is anticipated to post the quickest CAGR. This is primarily due to the increase in demand for biologics, a novel class of pharmaceuticals that has shown rapid growth in recent years. Aside from biologics, the market has witnessed the emergence of various types of precision medicine inventions, such as biomarker testing, cellular therapies, specific vaccines, blood products, and regenerative medicine in the form of stem cells. These drugs require both temperature- and time-controlled distribution.

The North America Biopharmaceutical Third-Party Logistics Market Holds A Significant Revenue Share In The Region

With a market share of about 39.1% and 119.8 billion dollars in revenue, North America emerged as the largest market for worldwide third-party logistics for biopharmaceuticals. This industry's fundamental engine of growth is the increased import and export of pharmaceutical chemicals, drugs, biologics, vaccines, and other related goods.

In addition to having high medical expenses, this area has the highest adoption of cutting-edge technologies overall. Because of this, North American pharmaceutical companies rely more and more on 3PL service providers to enhance storage and shipping, fueling the region's overall growth. However, the Asia-Pacific market remains second due to increased investment in R&D and an increase in the number of diagnoses of rare illnesses in the region; the Asia-Pacific market is anticipated to grow at the quickest CAGR. It is anticipated that this element will improve pharmaceutical product sales as well as their import and export.

Biopharmaceutical Third-Party Logistics Market Report Scope: